| Title | Date | PubMed ID |
|---|
| Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin. | 2013 Aug 13 | 23901101 |
| Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages. | 2013 May | 23177218 |
| Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein. | 2012 Jun 1 | 22518841 |
| Functional analyses of complement convertases using C3 and C5-depleted sera. | 2012 | 23071769 |
| Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. | 2011 Oct 27 | 21860027 |
| Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein. | 2011 Oct 14 | 21862585 |
| Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice. | 2011 Jul | 21502587 |
| Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. | 2011 Jan 27 | 21063021 |
| Structures of C3b in complex with factors B and D give insight into complement convertase formation. | 2010 Dec 24 | 21205667 |
| Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. | 2010 Oct | 20852386 |